Cargando…
Genetics and Therapies for GM2 Gangliosidosis
Tay-Sachs disease, caused by impaired β-N-acetylhexosaminidase activity, was the first GM2 gangliosidosis to be studied and one of the most severe and earliest lysosomal diseases to be described. The condition, associated with the pathological build-up of GM2 ganglioside, has acquired almost iconic...
Autores principales: | Cachón-González, María Begoña, Zaccariotto, Eva, Cox, Timothy Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040173/ https://www.ncbi.nlm.nih.gov/pubmed/29618308 http://dx.doi.org/10.2174/1566523218666180404162622 |
Ejemplares similares
-
GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021) -
Animal models of GM2 gangliosidosis: utility and limitations
por: Lawson, Cheryl A, et al.
Publicado: (2016) -
GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021) -
Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023) -
Characterization of glycan substrates accumulating in GM1 Gangliosidosis
por: Lawrence, Roger, et al.
Publicado: (2019)